Rijian Wang

Title: Rijian Wang: Innovator in Antibody Research

Introduction

Rijian Wang is a notable inventor based in Saugus, MA (US). He has made significant contributions to the field of antibody research, particularly in the development of anti-CD40 antibodies. With a total of 2 patents, his work has implications for transplant medicine and immunology.

Latest Patents

Rijian Wang's latest patents include innovations related to polynucleotides encoding anti-CD40 antibodies. The first patent focuses on antibodies that are specific for a particular epitope on CD40, which possess unique functional characteristics. This invention also covers fragments of these antibodies and their applications in reducing or treating transplant rejection and graft-versus-host disease. The second patent similarly addresses anti-CD40 antibodies and methods of administering them, emphasizing their potential therapeutic uses.

Career Highlights

Throughout his career, Rijian Wang has worked with esteemed institutions such as Beth Israel Deaconess Medical Center and Emory University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Rijian Wang's notable coworkers include Keith A Reimann and Christian P Larsen. Their collaborative efforts have further advanced the research and development of innovative antibody therapies.

Conclusion

Rijian Wang's contributions to antibody research, particularly in the area of anti-CD40 antibodies, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to improving medical treatments for transplant-related conditions.